By Deena Beasley (Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered ...

The new treatment will deliver chemotherapy directly to cancer cells. Read more at straitstimes.com. Read more at ...

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

Often, when young women approach their care teams with concerns about breast cancer, they're brushed aside. It’s our ...

A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

The RHOA personality was diagnosed with stage 1 invasive ductal carcinoma in November 2024. She recently reflected on the ...

Thousands of islanders are set to walk across Guernsey next month, to mark 10 years of a breast cancer charity's sunset walks ...

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug ...

Mutations in the PIK3CA gene are a key driver of breast cancer and are present in 35–40% of hormone receptor–positive breast ...